Talmadge JE - Search Results

1

Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation.

Pavletic SZ, Bociek RG, Foran JM, Rubocki RJ, Kuszynski CA, Wisecarver JL, Hatcher L, Lucas DM, Byrd JC, Grever MR, Joshi SS, Hardiman P, Smith LM, McGuire TR, Bierman PJ, Vose JM, Armitage JO, Talmadge JE. Pavletic SZ, et al. Among authors: talmadge je. Transplantation. 2003 Sep 15;76(5):877-81. doi: 10.1097/01.TP.0000084869.08639.A0. Transplantation. 2003. PMID: 14501873 Clinical Trial.

2

Clinical outcome of peripheral blood stem cell support.

Kessinger A, Armitage J, Bierman P, Bishop M, Joshi S, Reed E, Sharp G, Talmadge J, Vose J. Kessinger A, et al. Med Oncol. 1994;11(2):43-6. doi: 10.1007/BF02988829. Med Oncol. 1994. PMID: 7850263 Review.

3

Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vectors.

Watanabe T, Kuszynski C, Ino K, Heimann DG, Shepard HM, Yasui Y, Maneval DC, Talmadge JE. Watanabe T, et al. Among authors: talmadge je. Blood. 1996 Jun 15;87(12):5032-9. Blood. 1996. PMID: 8652816 Free article.

4

Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation.

Talmadge JE, Reed EC, Kessinger A, Kuszynski CA, Perry GA, Gordy CL, Mills KC, Thomas ML, Pirruccello SJ, Letheby BA, Arneson MA, Jackson JD. Talmadge JE, et al. Bone Marrow Transplant. 1996 Jan;17(1):101-9. Bone Marrow Transplant. 1996. PMID: 8673041

5

Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.

Mills KC, Gross TG, Varney ML, Heimann DG, Reed EC, Kessinger A, Talmadge JE. Mills KC, et al. Among authors: talmadge je. Bone Marrow Transplant. 1996 Jul;18(1):53-61. Bone Marrow Transplant. 1996. PMID: 8831996

6

Monocyte activation by an oral immunomodulator (bestatin) in lymphoma patients following autologous bone marrow transplantation.

Ino K, Bierman PJ, Varney ML, Heimann DG, Kuszynski CA, Walker SA, Talmadge JE. Ino K, et al. Among authors: talmadge je. Cancer Immunol Immunother. 1996 Dec;43(4):206-12. doi: 10.1007/s002620050323. Cancer Immunol Immunother. 1996. PMID: 9003465 Clinical Trial.

7

Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.

Talmadge JE, Reed E, Ino K, Kessinger A, Kuszynski C, Heimann D, Varney M, Jackson J, Vose JM, Bierman PJ. Talmadge JE, et al. Bone Marrow Transplant. 1997 Jan;19(2):161-72. doi: 10.1038/sj.bmt.1700626. Bone Marrow Transplant. 1997. PMID: 9116614 Clinical Trial.

8

Monocytes from mobilized stem cells inhibit T cell function.

Ino K, Singh RK, Talmadge JE. Ino K, et al. Among authors: talmadge je. J Leukoc Biol. 1997 May;61(5):583-91. doi: 10.1002/jlb.61.5.583. J Leukoc Biol. 1997. PMID: 9129207

9

GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cells in adhesion molecule expression.

Watanabe T, Dave B, Heimann DG, Lethaby E, Kessinger A, Talmadge JE. Watanabe T, et al. Among authors: talmadge je. Bone Marrow Transplant. 1997 Jun;19(12):1175-81. doi: 10.1038/sj.bmt.1700814. Bone Marrow Transplant. 1997. PMID: 9208110

10

Restoration of T and NK cell function in GM-CSF mobilized stem cell products from breast cancer patients by monocyte depletion.

Ageitos AG, Ino K, Ozerol I, Tarantolo S, Heimann DG, Talmadge JE. Ageitos AG, et al. Among authors: talmadge je. Bone Marrow Transplant. 1997 Jul;20(2):117-23. doi: 10.1038/sj.bmt.1700864. Bone Marrow Transplant. 1997. PMID: 9244414

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page